Kathryn Fitch, RN, MEd

Articles by Kathryn Fitch, RN, MEd

Real-World Evidence Associated With a First-Generation BTK Inhibitor in Patients With CLL/SLL

ByKathryn Fitch, RN, MEd,Michael Kolodziej, MD, FACP

March 10th 2022

The Value of Colonoscopic Colorectal Cancer Screening of Adults Aged 50 to 64

ByKathryn Fitch, RN, MEd,Bruce Pyenson, FSA, MAAA,Helen Blumen, MD, MBA,Thomas Weisman, MD, MBA,Art Small, MD

August 5th 2015

Screening commercially insured individuals for colorectal cancer is a high-value service, costing less per year of life saved than breast or cervical cancer screening.

Latest Updated Articles

Real-World Evidence Associated With a First-Generation BTK Inhibitor in Patients With CLL/SLL
Published: March 10th 2022 | Updated:
The Value of Colonoscopic Colorectal Cancer Screening of Adults Aged 50 to 64
Published: August 5th 2015 | Updated:

Kathryn Fitch, RN, MEd

Articles by Kathryn Fitch, RN, MEd

Real-World Evidence Associated With a First-Generation BTK Inhibitor in Patients With CLL/SLL

The Value of Colonoscopic Colorectal Cancer Screening of Adults Aged 50 to 64

Latest Updated Articles

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

Exploring Identity, Appearance Experiences Among Patients With Alopecia

Real-World Evidence Backs Acalabrutinib in CLL Care